Concepedia

Joy Guedia

JG

4

Publications

194

Citations

4

H-Index

2016

Active since

Affiliations

Zymeworks (Canada)(Current)

University of British Columbia

Joy Guedia is an author at Zymeworks (Canada) specializing in cancer therapeutics, tumor immunity, and tumor biology.

Top concepts

Publications per year

2016–2023

4

Publications

4

An anti-HER2 biparatopic antibody that induces unique HER2 clustering and complement-dependent cytotoxicity

Nina E. Weisser, Mário Sanches, Eric Escobar-Cabrera et al. · Nature Communications · 2023 · 141 citations · Full text

HIV-1 Tat exacerbates lipopolysaccharide-induced cytokine release via TLR4 signaling in the enteric nervous system

Joy Guedia, Paola Brun, Sukhada Bhave et al. · Scientific Reports · 2016 · 24 citations · Full text

Abstract 1005: The bispecific antibody zanidatamab's (ZW25's) unique mechanisms of action and durable anti-tumor activity in HER2-expressing cancers

Nina E. Weisser, Grant Wickman, Libin Abraham et al. · Cancer Research · 2021 · 18 citations

, , +21

Generation and structure-activity relationships of novel imidazo-thienopyridine based TLR7 agonists: application as payloads for immunostimulatory antibody drug-conjugates

Michael G. Brant, Graham A. E. Garnett, Joy Guedia et al. · Bioorganic & Medicinal Chemistry Letters · 2023 · 11 citations · Full text

Rows per page

1–4 of 4